Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Raises Price Target to $885
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly and Co (LLY) and increased the price target from $815 to $885.
April 30, 2024 | 5:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly and Co and increased the price target from $815 to $885.
The reiteration of an Overweight rating combined with a significant increase in the price target by a reputable analyst suggests a strong bullish sentiment towards Eli Lilly. This is likely to positively influence investor perception and could lead to a short-term increase in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100